prednisone has been researched along with Cancer of Nose in 43 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was also no difference in the survival between radiotherapy dosage | 1.32 | [Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma]. ( Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Xia, ZJ; Xu, RH, 2003) |
| "Despite the dramatic response of Hodgkin's disease to intensive chemotherapy, the skin lesion was rapidly transformed into squamous cell carcinoma in 10 weeks." | 1.26 | Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? ( Poleksic, S; Yeung, KY, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.65) | 18.7374 |
| 1990's | 5 (11.63) | 18.2507 |
| 2000's | 26 (60.47) | 29.6817 |
| 2010's | 10 (23.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vähämurto, P | 1 |
| Mannisto, S | 1 |
| Pollari, M | 1 |
| Karjalainen-Lindsberg, ML | 1 |
| Mäkitie, AA | 1 |
| Leppä, S | 1 |
| Liu, QF | 2 |
| Wang, WH | 3 |
| Wang, SL | 3 |
| Liu, YP | 3 |
| Huang, WT | 1 |
| Lu, N | 1 |
| Zhou, LQ | 1 |
| Ouyang, H | 1 |
| Jin, J | 4 |
| Li, YX | 4 |
| Kazi, M | 1 |
| Ikram, M | 1 |
| Junaid, M | 1 |
| Rahman, SM | 1 |
| Bhat, W | 1 |
| Wiper, JD | 1 |
| Platt, AJ | 1 |
| Vasconcelos, Pd | 1 |
| Ferreira, C | 1 |
| Soares-Almeida, L | 1 |
| Filipe, P | 1 |
| Huang, L | 1 |
| Yuan, B | 1 |
| Wu, H | 1 |
| Chu, H | 1 |
| Liu, Y | 1 |
| Wu, S | 1 |
| Li, H | 1 |
| Lu, H | 4 |
| Chen, H | 1 |
| Wang, B | 3 |
| Li, XQ | 2 |
| Ma, X | 3 |
| Hong, X | 2 |
| Guo, Y | 4 |
| Savage, KJ | 1 |
| Ma, HH | 1 |
| Qian, LT | 1 |
| Pan, HF | 1 |
| Yang, L | 1 |
| Zhang, HY | 1 |
| Wang, ZH | 1 |
| Ma, J | 1 |
| Zhao, YF | 1 |
| Gao, J | 1 |
| Wu, AD | 1 |
| Pang, Z | 1 |
| Gu, YJ | 1 |
| Guo, X | 1 |
| Xu, G | 1 |
| Wang, HF | 1 |
| He, G | 1 |
| Xie, K | 1 |
| Wang, ZY | 1 |
| Wang, H | 1 |
| Song, YW | 2 |
| Qi, SN | 1 |
| Fang, H | 2 |
| Liu, XF | 3 |
| Yu, ZH | 3 |
| Kost Al, M | 1 |
| Kost Alová, M | 1 |
| Belada, D | 1 |
| Laco, J | 1 |
| Huang, H | 1 |
| Lin, Z | 1 |
| Lin, X | 1 |
| Cai, Q | 1 |
| Xia, Z | 1 |
| Jiang, W | 1 |
| Baran, AM | 1 |
| Reifenberger, J | 1 |
| Helbig, D | 1 |
| Wang, L | 1 |
| Xia, ZJ | 4 |
| Huang, HQ | 5 |
| Lu, Y | 1 |
| Zhang, YJ | 2 |
| Yih, WY | 1 |
| Stewart, JC | 1 |
| Kratochvil, FJ | 1 |
| Zieper, MB | 1 |
| Sawada, M | 1 |
| Yamada, T | 1 |
| Tsurumi, H | 1 |
| Moriwaki, H | 1 |
| Li, YH | 2 |
| Jiang, WQ | 3 |
| Xu, RH | 2 |
| Lin, TY | 4 |
| He, YJ | 2 |
| Guan, ZZ | 4 |
| Smyth, EF | 1 |
| Bartlett, RJ | 1 |
| Shields, ML | 1 |
| White, TJ | 1 |
| Wengraf, C | 1 |
| Kouzaki, H | 1 |
| Kitanishi, T | 1 |
| Kitano, H | 1 |
| Suzuki, M | 1 |
| Nie, DH | 1 |
| Hu, WH | 1 |
| Gao, YH | 1 |
| Wu, Y | 1 |
| Zhang, SP | 1 |
| Robak, E | 1 |
| Góra-Tybor, J | 1 |
| Kordek, R | 1 |
| Wawrzyniak, E | 1 |
| Bartkowiak, J | 1 |
| Bednarek, A | 1 |
| Constantinou, M | 1 |
| Kałuzewski, B | 1 |
| Robak, T | 1 |
| Pan, ZH | 1 |
| Lin, XB | 1 |
| Xia, YF | 2 |
| Peng, YL | 1 |
| Cai, QQ | 1 |
| Acero, J | 1 |
| Navarro-Cuellar, C | 1 |
| Menarguez, J | 1 |
| Herencia, H | 1 |
| Navarro-Vila, C | 1 |
| Yao, B | 2 |
| Sun, YT | 1 |
| Xiao, J | 1 |
| Wang, SS | 1 |
| Huang, Y | 1 |
| Chen, LK | 1 |
| Wang, BY | 1 |
| Hong, XN | 1 |
| Yin, JL | 1 |
| Lu, HF | 1 |
| Ma, XJ | 1 |
| He, YF | 1 |
| Lu, TX | 1 |
| Xian, CG | 1 |
| Lu, JJ | 1 |
| Li, J | 1 |
| Rajnics, P | 1 |
| Krenács, L | 1 |
| Kenéz, A | 1 |
| Járay, Z | 1 |
| Bagdi, E | 1 |
| Demeter, J | 1 |
| Braczkowski, R | 1 |
| Zubelewicz, B | 1 |
| Muc-Wierzgoń, M | 1 |
| Baranowski, M | 1 |
| Hughes, RG | 1 |
| Morgan, DW | 1 |
| Derbel, M | 1 |
| Ben Zina, Z | 1 |
| Sellami, D | 1 |
| Ben Ayed, H | 1 |
| Chaabouni, M | 1 |
| Daoud, J | 1 |
| Frikha, M | 1 |
| Abdelmoula, M | 1 |
| Tsujimura, H | 1 |
| Takagi, T | 1 |
| Tamaru, J | 1 |
| Sakai, C | 1 |
| Wong, KF | 1 |
| Chan, JK | 1 |
| Cheung, MM | 1 |
| So, JC | 1 |
| Mikhaeel, NG | 1 |
| Spittle, MF | 1 |
| Kim, WS | 1 |
| Song, SY | 1 |
| Ahn, YC | 1 |
| Ko, YH | 1 |
| Baek, CH | 1 |
| Kim, DY | 1 |
| Yoon, SS | 1 |
| Lee, HG | 1 |
| Kang, WK | 1 |
| Lee, HJ | 1 |
| Park, CH | 1 |
| Park, K | 1 |
| Poleksic, S | 1 |
| Yeung, KY | 1 |
| Noorduyn, LA | 1 |
| Torenbeek, R | 1 |
| van der Valk, P | 1 |
| Drosten, PB | 1 |
| Snow, GB | 2 |
| Balm, AJ | 1 |
| Ossenkoppele, GJ | 2 |
| Meyer, CJ | 1 |
| Wollner, N | 1 |
| Mandell, L | 1 |
| Filippa, D | 1 |
| Exelby, P | 1 |
| McGowan, N | 1 |
| Lieberman, P | 1 |
| Mol, JJ | 1 |
| Karim, AB | 1 |
| Veldhuijzen, RW | 1 |
| Nauta, JP | 1 |
| Langenhuijsen, MM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Gemcitabine, Oxaliplatin and Pegaspargase and Etoposide, Vincristine, Doxorubicin, Cyclophosphamide and Prednisone as First-line Chemotherapy in Patients With NK/T-cell Lymphoma：a Prospective Randomized Phase III Study[NCT02359162] | Phase 3 | 50 participants (Actual) | Interventional | 2015-05-31 | Terminated (stopped due to The study is out of date) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for prednisone and Cancer of Nose
| Article | Year |
|---|---|
Angiocentric T-cell lymphoma presenting as midface destructive lesion: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, T-C | 2002 |
[Long-term survival after nasal NK/T cell lymphoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyclophosphamide; Diagnosis | 2008 |
5 trials available for prednisone and Cancer of Nose
| Article | Year |
|---|---|
Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad | 2010 |
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; H | 2009 |
Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; China; Combined Modality Therapy; | 2009 |
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophospha | 2011 |
Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclopho | 2012 |
36 other studies available for prednisone and Cancer of Nose
| Article | Year |
|---|---|
Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cyclophosphamide; Disease P | 2019 |
Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy | 2014 |
Nasal T cell lymphoma: a rare entity.
Topics: Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biopsy; CD56 Antigen; Che | 2014 |
Clinical and histological resolution of a basal cell carcinoma in a patient undergoing concurrent treatment of B-cell lymphoma with systemic R-CHOP.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2014 |
Multifocal primary cutaneous extranodal NK/T lymphoma nasal type.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Fatal O | 2016 |
Comparative Study of L-Asparaginase-Based LOP Regimen Over CHOP Regimen Before Radiotherapy for Stage IIE Extranodal Nasal Type NK/T Cell Lymphoma: A Study of 2 Centers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparagi | 2017 |
Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 2008 |
Prognosis and primary therapy in peripheral T-cell lymphomas.
Topics: Anaplastic Lymphoma Kinase; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair | 2008 |
[Expression and significance of p53-related proteins and LMP-1 in nasal NK/T-cell lymphoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclin-Dependent Kinase Inh | 2009 |
Cutaneous natural killer (NK) / T-cell lymphoma: nasal type with extensive facial destruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; | 2009 |
[NK/T-cell lymphoma, nasal type with cutaneous dissemination].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Doxorubic | 2012 |
[Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Histiocytosis, | 2002 |
[Clinical analysis of 75 patients with nasopharyngeal non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2003 |
Richter's syndrome: a novel presentation.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; | 2003 |
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cycloph | 2004 |
[Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co | 2004 |
Richter syndrome first manifesting as cutaneous B-cell lymphoma clonally distinct from primary B-cell chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 2005 |
[Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; | 2005 |
Naso-maxillary non-Hodgkin lymphoma associated with methotrexate treatment in a patient with rheumatoid arthritis.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antirheumatic | 2006 |
[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Topics: Adolescent; Adult; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Combine | 2006 |
[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; | 2006 |
[Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined | 2006 |
[Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma | 2006 |
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined | 2006 |
Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorub | 2007 |
[A case of recurrent untreated non-hodgkin's lymphoma localized in the nasopharynx and maxillary sinuses after a 10-year remission].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Lymphocyt | 1996 |
B-cell lymphoma with extensive cutaneous involvement presenting to the ENT surgeon.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; | 1998 |
[Exophthalmos and blindness disclosing an ethmoidal-maxillary malignant non-Hodgkin's T-cell lymphoma. Apropos of a case].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormon | 1999 |
Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Appendic | 2000 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin | 2001 |
Nasal natural killer-cell lymphoma: a disease with very poor prognosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Debride | 2000 |
CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival | 2001 |
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans; | 1978 |
Sinonasal non-Hodgkin's lymphomas and Wegener's granulomatosis: a clinicopathological study.
Topics: Adult; Antibodies, Neoplasm; Cyclophosphamide; Female; Follow-Up Studies; Granulomatosis with Polyan | 1991 |
Primary nasal-paranasal oropharyngeal lymphoma in the pediatric age group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid | 1990 |
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II non-Hodgkin's lymphoma of the upper digestive and respiratory tract.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1987 |